Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

24.31
Delayed Data
As of Sep 03
 -0.80 / -3.19%
Today’s Change
12.17
Today|||52-Week Range
28.66
+57.14%
Year-to-Date
No recent news for Insmed Inc.

Today’s Trading

Previous close25.11
Today’s open25.06
Day’s range24.18 - 25.56
Volume359,543
Average volume (3 months)415,959
Market cap$1.6B
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)-15.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book6.72

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...-3.36-9.11%
SAGESAGE Therapeutics In...-1.43-2.61%
IRWDIronwood Pharmaceuti...-0.43-3.87%
MNKDMannkind Corp-0.16-4.16%
Data as of 09/03/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$0.00
Annual profit (last year)-$79.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William H. Lewis
Chief Financial Officer
Andrew T. Drechsler
Corporate headquarters
Bridgewater, New Jersey

Forecasts

Partner Offers